The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Cholera Vaccine Market Research Report 2025
Synopsis
The global Oral Cholera Vaccine market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 146.3 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
This report aims to provide a comprehensive presentation of the global market for Oral Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Cholera Vaccine.
Report Scope
The Oral Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Cholera Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Segment by Application
Preventive Campaigns
Outbreak Response
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Cholera Vaccine market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 146.3 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
This report aims to provide a comprehensive presentation of the global market for Oral Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Cholera Vaccine.
Report Scope
The Oral Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Cholera Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Segment by Application
Preventive Campaigns
Outbreak Response
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Cholera Vaccine Market Overview
1.1 Product Overview and Scope of Oral Cholera Vaccine
1.2 Oral Cholera Vaccine Segment by Type
1.2.1 Global Oral Cholera Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Euvichol-Plus
1.2.3 DUKORAL
1.2.4 Shanchol
1.2.5 Others
1.3 Oral Cholera Vaccine Segment by Application
1.3.1 Global Oral Cholera Vaccine Market Value by Application: (2024-2030)
1.3.2 Preventive Campaigns
1.3.3 Outbreak Response
1.4 Global Oral Cholera Vaccine Market Size Estimates and Forecasts
1.4.1 Global Oral Cholera Vaccine Revenue 2019-2030
1.4.2 Global Oral Cholera Vaccine Sales 2019-2030
1.4.3 Global Oral Cholera Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Cholera Vaccine Market Competition by Manufacturers
2.1 Global Oral Cholera Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Cholera Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Cholera Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Oral Cholera Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Cholera Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Cholera Vaccine, Product Type & Application
2.7 Oral Cholera Vaccine Market Competitive Situation and Trends
2.7.1 Oral Cholera Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Cholera Vaccine Players Market Share by Revenue
2.7.3 Global Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Cholera Vaccine Retrospective Market Scenario by Region
3.1 Global Oral Cholera Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Cholera Vaccine Global Oral Cholera Vaccine Sales by Region: 2019-2030
3.2.1 Global Oral Cholera Vaccine Sales by Region: 2019-2024
3.2.2 Global Oral Cholera Vaccine Sales by Region: 2025-2030
3.3 Global Oral Cholera Vaccine Global Oral Cholera Vaccine Revenue by Region: 2019-2030
3.3.1 Global Oral Cholera Vaccine Revenue by Region: 2019-2024
3.3.2 Global Oral Cholera Vaccine Revenue by Region: 2025-2030
3.4 North America Oral Cholera Vaccine Market Facts & Figures by Country
3.4.1 North America Oral Cholera Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Cholera Vaccine Sales by Country (2019-2030)
3.4.3 North America Oral Cholera Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Cholera Vaccine Market Facts & Figures by Country
3.5.1 Europe Oral Cholera Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Cholera Vaccine Sales by Country (2019-2030)
3.5.3 Europe Oral Cholera Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Cholera Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Cholera Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Cholera Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Cholera Vaccine Market Facts & Figures by Country
3.7.1 Latin America Oral Cholera Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Cholera Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Oral Cholera Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Cholera Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Cholera Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Cholera Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Cholera Vaccine Sales by Type (2019-2030)
4.1.1 Global Oral Cholera Vaccine Sales by Type (2019-2024)
4.1.2 Global Oral Cholera Vaccine Sales by Type (2025-2030)
4.1.3 Global Oral Cholera Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Oral Cholera Vaccine Revenue by Type (2019-2030)
4.2.1 Global Oral Cholera Vaccine Revenue by Type (2019-2024)
4.2.2 Global Oral Cholera Vaccine Revenue by Type (2025-2030)
4.2.3 Global Oral Cholera Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Oral Cholera Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Cholera Vaccine Sales by Application (2019-2030)
5.1.1 Global Oral Cholera Vaccine Sales by Application (2019-2024)
5.1.2 Global Oral Cholera Vaccine Sales by Application (2025-2030)
5.1.3 Global Oral Cholera Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Oral Cholera Vaccine Revenue by Application (2019-2030)
5.2.1 Global Oral Cholera Vaccine Revenue by Application (2019-2024)
5.2.2 Global Oral Cholera Vaccine Revenue by Application (2025-2030)
5.2.3 Global Oral Cholera Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Oral Cholera Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PaxVax
6.1.1 PaxVax Corporation Information
6.1.2 PaxVax Description and Business Overview
6.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PaxVax Oral Cholera Vaccine Product Portfolio
6.1.5 PaxVax Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Oral Cholera Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Valneva
6.3.1 Valneva Corporation Information
6.3.2 Valneva Description and Business Overview
6.3.3 Valneva Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Valneva Oral Cholera Vaccine Product Portfolio
6.3.5 Valneva Recent Developments/Updates
6.4 EuBiologics
6.4.1 EuBiologics Corporation Information
6.4.2 EuBiologics Description and Business Overview
6.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EuBiologics Oral Cholera Vaccine Product Portfolio
6.4.5 EuBiologics Recent Developments/Updates
6.5 United Biotech
6.5.1 United Biotech Corporation Information
6.5.2 United Biotech Description and Business Overview
6.5.3 United Biotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 United Biotech Oral Cholera Vaccine Product Portfolio
6.5.5 United Biotech Recent Developments/Updates
6.6 Vabiotech
6.6.1 Vabiotech Corporation Information
6.6.2 Vabiotech Description and Business Overview
6.6.3 Vabiotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vabiotech Oral Cholera Vaccine Product Portfolio
6.6.5 Vabiotech Recent Developments/Updates
6.7 PaxVax
6.6.1 PaxVax Corporation Information
6.6.2 PaxVax Description and Business Overview
6.6.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PaxVax Oral Cholera Vaccine Product Portfolio
6.7.5 PaxVax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Cholera Vaccine Industry Chain Analysis
7.2 Oral Cholera Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Cholera Vaccine Production Mode & Process
7.4 Oral Cholera Vaccine Sales and Marketing
7.4.1 Oral Cholera Vaccine Sales Channels
7.4.2 Oral Cholera Vaccine Distributors
7.5 Oral Cholera Vaccine Customers
8 Oral Cholera Vaccine Market Dynamics
8.1 Oral Cholera Vaccine Industry Trends
8.2 Oral Cholera Vaccine Market Drivers
8.3 Oral Cholera Vaccine Market Challenges
8.4 Oral Cholera Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
